QGEN Feb 2025 30.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:54PM EDT. Market open.
| Previous close | 0.6200 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 1.6500 |
| Strike | 30.00 |
| Expiry date | 2025-02-21 |
| Day's range | 0.6200 - 0.6200 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
ZacksCan QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?
QIAGEN and Bio-Manguinhos/Fiocruz team up to enhance malaria and dengue detection in Brazil's national screening programs.
GlobeNewswireQIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil’s national screening programs
Advanced PCR-based screening platform deployed nationwide across 30 laboratories provides new capabilities to detect malaria, HIV, HCV, and HBV in blood donations // Advanced capabilities support epidemiological surveillance of ongoing dengue outbreak in Brazil with unique chemistry developed by QIAGEN and Bio-Manguinhos/Fiocruz // Partnership highlights QIAGEN’s commitment to custom and OEM solutions, technology transfer and long-term supportVenlo, the Netherlands, Rio de Janeiro, Brazil, Sept.
Simply Wall St.With 79% institutional ownership, Qiagen N.V. (NYSE:QGEN) is a favorite amongst the big guns
Key Insights Given the large stake in the stock by institutions, Qiagen's stock price might be vulnerable to their...
© 2024 Yahoo. All rights reserved.